These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 31032883)
1. Risk-reducing medications for primary breast cancer: a network meta-analysis. Mocellin S; Goodwin A; Pasquali S Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012191. PubMed ID: 31032883 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160 [TBL] [Abstract][Full Text] [Related]
4. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Nelson HD; Fu R; Zakher B; Pappas M; McDonagh M JAMA; 2019 Sep; 322(9):868-886. PubMed ID: 31479143 [TBL] [Abstract][Full Text] [Related]
5. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer. Bui KT; Willson ML; Goel S; Beith J; Goodwin A Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074 [TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. Mocellin S; Pilati P; Briarava M; Nitti D J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582062 [TBL] [Abstract][Full Text] [Related]
7. Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer. Riemsma R; Forbes CA; Kessels A; Lykopoulos K; Amonkar MM; Rea DW; Kleijnen J Breast Cancer Res Treat; 2010 Aug; 123(1):9-24. PubMed ID: 20535542 [TBL] [Abstract][Full Text] [Related]
8. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review. Atakpa EC; Thorat MA; Cuzick J; Brentnall AR Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis. Jakob T; Tesfamariam YM; Macherey S; Kuhr K; Adams A; Monsef I; Heidenreich A; Skoetz N Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013020. PubMed ID: 33270906 [TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Gibson LJ; Dawson C; Lawrence DH; Bliss JM Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488 [TBL] [Abstract][Full Text] [Related]
11. Hormonal therapies for early breast cancer: systematic review and economic evaluation. Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808 [TBL] [Abstract][Full Text] [Related]
12. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Parry Smith WR; Papadopoulou A; Thomas E; Tobias A; Price MJ; Meher S; Alfirevic Z; Weeks AD; Hofmeyr GJ; Gülmezoglu AM; Widmer M; Oladapo OT; Vogel JP; Althabe F; Coomarasamy A; Gallos ID Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012754. PubMed ID: 33232518 [TBL] [Abstract][Full Text] [Related]
13. Selective oestrogen receptor modulators (SERMs) for endometriosis. van Hoesel MH; Chen YL; Zheng A; Wan Q; Mourad SM Cochrane Database Syst Rev; 2021 May; 5(5):CD011169. PubMed ID: 33973648 [TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Romero SA; Young K; Hickey M; Su HI Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436 [TBL] [Abstract][Full Text] [Related]
15. Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis. Adams A; Jakob T; Huth A; Monsef I; Ernst M; Kopp M; Caro-Valenzuela J; Wöckel A; Skoetz N Cochrane Database Syst Rev; 2024 Jul; 7(7):CD013451. PubMed ID: 38979716 [TBL] [Abstract][Full Text] [Related]